These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9192810)

  • 1. Overexpression of CDC25A and CDC25B in head and neck cancers.
    Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
    Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
    Wu W; Fan YH; Kemp BL; Walsh G; Mao L
    Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
    Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
    Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
    Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
    Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC25 phosphatases as potential human oncogenes.
    Galaktionov K; Lee AK; Eckstein J; Draetta G; Meckler J; Loda M; Beach D
    Science; 1995 Sep; 269(5230):1575-7. PubMed ID: 7667636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases.
    Ferguson AM; White LS; Donovan PJ; Piwnica-Worms H
    Mol Cell Biol; 2005 Apr; 25(7):2853-60. PubMed ID: 15767688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
    Kudo Y; Yasui W; Ue T; Yamamoto S; Yokozaki H; Nikai H; Tahara E
    Jpn J Cancer Res; 1997 Oct; 88(10):947-52. PubMed ID: 9414655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
    Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.
    Naeger LK; Goodwin EC; Hwang ES; DeFilippis RA; Zhang H; DiMaio D
    Cell Growth Differ; 1999 Jun; 10(6):413-22. PubMed ID: 10392903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome-dependent degradation of human CDC25B phosphatase.
    Cans C; Ducommun B; Baldin V
    Mol Biol Rep; 1999 Apr; 26(1-2):53-7. PubMed ID: 10363647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.
    Sur S; Agrawal DK
    Mol Cell Biochem; 2016 May; 416(1-2):33-46. PubMed ID: 27038604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two CDC25 homologues are differentially expressed during mouse development.
    Wickramasinghe D; Becker S; Ernst MK; Resnick JL; Centanni JM; Tessarollo L; Grabel LB; Donovan PJ
    Development; 1995 Jul; 121(7):2047-56. PubMed ID: 7635051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea.
    Nishijima H; Nishitani H; Seki T; Nishimoto T
    J Cell Biol; 1997 Sep; 138(5):1105-16. PubMed ID: 9281587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
    Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
    BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cdc25B phosphatase is essential for the G2/M phase transition in human cells.
    Lammer C; Wagerer S; Saffrich R; Mertens D; Ansorge W; Hoffmann I
    J Cell Sci; 1998 Aug; 111 ( Pt 16)():2445-53. PubMed ID: 9683638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase.
    Mils V; Baldin V; Goubin F; Pinta I; Papin C; Waye M; Eychene A; Ducommun B
    Oncogene; 2000 Mar; 19(10):1257-65. PubMed ID: 10713667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
    Hoffmann I; Draetta G; Karsenti E
    EMBO J; 1994 Sep; 13(18):4302-10. PubMed ID: 7523110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.
    Miyata H; Doki Y; Shiozaki H; Inoue M; Yano M; Fujiwara Y; Yamamoto H; Nishioka K; Kishi K; Monden M
    Clin Cancer Res; 2000 Dec; 6(12):4859-65. PubMed ID: 11156245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis.
    Karlsson C; Katich S; Hagting A; Hoffmann I; Pines J
    J Cell Biol; 1999 Aug; 146(3):573-84. PubMed ID: 10444066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients.
    Broggini M; Buraggi G; Brenna A; Riva L; Codegoni AM; Torri V; Lissoni AA; Mangioni C; D'Incalci M
    Anticancer Res; 2000; 20(6C):4835-40. PubMed ID: 11205229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.